Skip to Content
Profiles in generosity

Stephen and Karen Kaufman

Boston, Massachusetts
October 22, 2013

Steve earned an MIT degree in economics and engineering in 1963 and an MBA from Harvard in 1965. He retired as chairman and CEO of Arrow Electronics and is now a senior lecturer of business administration at Harvard Business School. Karen had a successful marketing career in Manhattan before moving to Boston. She is now cochair of the Council for the Arts at MIT. The couple has traveled to six continents and 100 countries. “We want to see all the globe,” Karen says.

Stephen and Karen Kaufman

“I established a unitrust to support teaching and innovation because a unitrust is an effective way to make a gift to MIT and to preserve income for myself for life. The unitrust is invested in the MIT endowment, which I view as much safer than corporate bonds. In fact, one might argue that MIT will have a better credit rating someday than the U.S. government, plus a better yield, at 5 percent of the market value of the trust —and potential increases over time. The endowment invests in private-equity deals, real estate, venture capital funds, and hedge funds, some of which are not open to individuals like me, so it provides me with access and diversification. And when I invest in an institution like MIT, I’m comfortable that there’s a broad number of people involved in managing my money and someone’s always watching the ship.”

Please consider your own gift to MIT.
For information, contact Judy Sager: 617-253-6463; jsager@mit.edu. Or visit giving.mit.edu/ways/invest-endowment.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.